奥翔药业,603229,收入构成,报告日期,2019-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
原料药及中间体,30730,14832,15898,51.73%,99.71%
其他（补充）,62,15,47,75.74%,0.29%

奥翔药业,603229,收入构成,报告日期,2018-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
原料药及中间体,24389,13498,10890,44.65%,100%

奥翔药业,603229,收入构成,报告日期,2017-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,31,19,12,39.62%,0.08%
原料药及中间体,23988,9492,14496,60.43%,99.92%


